Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma

Affiliations

• ¹ University of California Los Angeles (UCLA) and Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, USA. aribas@mednet.ucla.edu.
• ² UCSF Medical Center, San Francisco, CA, USA.
• ³ Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
• ⁴ Princess Margaret Cancer Centre, Toronto, ON, Canada.
• ⁵ Northwestern Memorial Hospital, Chicago, IL, USA.
• ⁶ HonorHealth Research Institute, Scottsdale, AZ, USA.
• ⁷ Washington University School of Medicine, St. Louis, MO, USA.
• ⁸ Massachusetts General Hospital, Boston, MA, USA.
• ⁹ Mount Sinai Medical Center, Miami Beach, FL, USA.
• ¹⁰ Segal Cancer Center, Jewish General Hospital, Rossy Cancer Network, McGill University, Montreal, QC, Canada.
• ¹¹ University of California Los Angeles (UCLA) and Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, USA.
• ¹² AstraZeneca, Gaithersburg, MD, USA.
• ¹³ Gustave Roussy Cancer Campus and Paris-Saclay University, Villejuif, France.